Clinical Trial: Implementing Low-Barrier HCV Treatment in a Jail Setting

U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953479) titled 'Implementing Low-Barrier HCV Treatment in a Jail Setting' on April 16.

Brief Summary: The goal of this clinical trial is to learn whether a low-barrier treatment program can help people with hepatitis C virus (HCV) who are in jail start and complete treatment more easily. This study focuses on adults at the Rhode Island Department of Corrections who have active HCV and are awaiting trial.

The study asks:

* Can a simplified, low-barrier HCV treatment program work in a jail setting?

* Do participants finish treatment and get cured using this approach?

All participants will receive a 12-week course of the HCV medication sofosbuvir/ve...